• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is Bisoprolol Underutilized in U.S. Heart Failure Patients?比索洛尔在美国心力衰竭患者中是否未得到充分利用？
JACC Adv. 2024 Sep 26;3(11):101290. doi: 10.1016/j.jacadv.2024.101290. eCollection 2024 Nov.
2
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.β受体阻滞剂在慢性心力衰竭和慢性阻塞性肺疾病患者中的差异：一项随机交叉试验。
J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.
3
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.心力衰竭、并发慢性阻塞性肺疾病与β受体阻滞剂使用之间的关系：一项丹麦全国队列研究。
Eur J Heart Fail. 2018 Mar;20(3):548-556. doi: 10.1002/ejhf.1045. Epub 2017 Nov 20.
4
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.卡维地洛、比索洛尔和美托洛尔在合并心力衰竭和慢性阻塞性肺疾病患者中的应用
Medicine (Baltimore). 2016 Feb;95(5):e2427. doi: 10.1097/MD.0000000000002427.
5
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.阻塞性气道疾病患者使用不同β1-肾上腺素能受体选择性的β受体阻滞剂的长期临床影响比较：一项基于意大利人群的队列研究。
Front Pharmacol. 2018 Oct 25;9:1212. doi: 10.3389/fphar.2018.01212. eCollection 2018.
6
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.β受体阻滞剂选择性对慢性阻塞性肺疾病合并充血性心力衰竭患者长期预后的影响。
Int J Chron Obstruct Pulmon Dis. 2015 Mar 5;10:515-23. doi: 10.2147/COPD.S79942. eCollection 2015.
7
[Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].[β受体阻滞剂在心血管疾病合并慢性阻塞性肺疾病患者中的应用可能性与局限性]
Kardiologiia. 2021 Oct 30;61(10):89-98. doi: 10.18087/cardio.2021.10.n1119.
8
Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.接受卡维地洛、比索洛尔或酒石酸美托洛尔治疗的老年心力衰竭患者：死亡风险
Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):81-90. doi: 10.1002/pds.4132. Epub 2016 Nov 16.
9
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.β受体阻滞剂在心力衰竭和慢性阻塞性肺疾病患者中的选择和可互换性：一项意大利基于登记的队列研究。
Sci Rep. 2019 Aug 7;9(1):11465. doi: 10.1038/s41598-019-47967-y.
10
The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.慢性阻塞性肺疾病（COPD）和充血性心力衰竭患者中β-肾上腺素能受体阻滞剂的评估：一项全国性研究。
Int J Chron Obstruct Pulmon Dis. 2017 Aug 26;12:2573-2581. doi: 10.2147/COPD.S141694. eCollection 2017.

本文引用的文献

1
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.比索洛尔在慢性阻塞性肺疾病高危加重患者中的应用：BICS 随机临床试验。
JAMA. 2024 Aug 13;332(6):462-470. doi: 10.1001/jama.2024.8771.
2
Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project.设计一项嵌入电子健康记录的实用临床试验：VA 的利尿剂比较项目。
Contemp Clin Trials. 2022 May;116:106754. doi: 10.1016/j.cct.2022.106754. Epub 2022 Apr 4.
3
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
4
Metoprolol for the Prevention of Acute Exacerbations of COPD.美托洛尔预防 COPD 急性加重。
N Engl J Med. 2019 Dec 12;381(24):2304-2314. doi: 10.1056/NEJMoa1908142. Epub 2019 Oct 20.
5
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.慢性心力衰竭患者中慢性阻塞性肺疾病的患病率及预后影响：来自GISSI-HF试验的数据。
Cardiology. 2017;136(2):128-137. doi: 10.1159/000448166. Epub 2016 Sep 8.
6
Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.卡维地洛、奈必洛尔与比索洛尔治疗中度心力衰竭的多参数比较：CARNEBI试验
Int J Cardiol. 2013 Oct 3;168(3):2134-40. doi: 10.1016/j.ijcard.2013.01.277. Epub 2013 Mar 16.
7
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.β受体阻滞剂在慢性心力衰竭和慢性阻塞性肺疾病患者中的差异：一项随机交叉试验。
J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.
8
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.β-肾上腺素能受体拮抗剂对人β1、β2和β3肾上腺素能受体的选择性。
Br J Pharmacol. 2005 Feb;144(3):317-22. doi: 10.1038/sj.bjp.0706048.

Is Bisoprolol Underutilized in U.S. Heart Failure Patients?

作者信息

Singh Ravnit, Prakash Atul, Ahmad Madhia B, Conroy Daniel P

机构信息

Division of Cardiology, Saint Michael's Medical Center, Newark, New Jersey, USA.

Division of Cardiology, St Mary's General Hospital, Passaic, New Jersey, USA.

出版信息

JACC Adv. 2024 Sep 26;3(11):101290. doi: 10.1016/j.jacadv.2024.101290. eCollection 2024 Nov.

DOI:10.1016/j.jacadv.2024.101290
PMID:39385945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460626/
Abstract
摘要